Page last updated: 2024-11-05

tolazoline and Ureteral Obstruction

tolazoline has been researched along with Ureteral Obstruction in 1 studies

Tolazoline: A vasodilator that apparently has direct actions on blood vessels and also increases cardiac output. Tolazoline can interact to some degree with histamine, adrenergic, and cholinergic receptors, but the mechanisms of its therapeutic effects are not clear. It is used in treatment of persistent pulmonary hypertension of the newborn.
tolazoline : A member of the class of imidazoles that is 4,5-dihydro-1H-imidazole substituted by a benzyl group.

Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Huland, H1
Gonnermann, D1
Leichtweiss, HP1
Dietrich-Hennings, R1

Other Studies

1 other study available for tolazoline and Ureteral Obstruction

ArticleYear
Reversibility of preglomerular active vasoconstriction in the first weeks after complete unilateral ureteral obstruction by inhibition of prostaglandin synthesis.
    The Journal of urology, 1983, Volume: 130, Issue:4

    Topics: Animals; Dogs; Female; Hydronephrosis; Kidney Glomerulus; Male; Prostaglandin Antagonists; Renal Cir

1983